PubMed:23619181 JSONTXT

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":53,"end":75},"obj":"HP_0002910"},{"id":"T2","span":{"begin":282,"end":293},"obj":"HP_0001397"},{"id":"T3","span":{"begin":430,"end":440},"obj":"HP_0002960"},{"id":"T4","span":{"begin":536,"end":550},"obj":"HP_0002608"},{"id":"T5","span":{"begin":568,"end":578},"obj":"HP_0003198"}],"text":"[In Process Citation].\nLeicht erhöhte Transaminasen.\nElevated transaminases in asymptomatic patients can be detected in more than 5 % of the investigations. If there are no obvious reasons, the finding should be confirmed within the next 3 months. Frequent causes are non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcohol, hepatitis B or C, hemochromatosis and drugs or toxins. Rarer causes are autoimmune hepatitis, M. Wilson and α1-antitrypsine deficiency. There are also non-hepatic causes such as celiac disease or hemolysis and myopathies in the case of an exclusive increase of ASAT. I recommend a two-step investigational procedure; the more frequent causes are examined first before the rare causes are studied. The value of the proposed investigations is discussed."}